Impairment of fertility and its preservation in patients undergoing systemic chemotherapy for Hodgkin lymphoma, summary and authors experiences
Authors:
L. Šmardová 1; M. Huser 2; Z. Král 1; I. Crha 2; I. Vášová 1; B. Wagnerová 1; J. Mayer 1; J. Vorlíček 1
Authors‘ workplace:
Interní hematoonkologická klinika, FN Brno
1; Gynekologicko-porodnická klinika, FN Brno
2
Published in:
Transfuze Hematol. dnes,11, 2005, No. 4, p. 162-169.
Category:
Comprehensive Reports, Original Papers, Case Reports
Overview
The most serious problem resulting from the chemotherapy of patients with Hodgkin lymphoma represents progression into the late effects of treatment, including gonadal toxicity. Consequently authors present here summary of risks regarding early ovarial failure in women and impairment of testicular function in men that are treated by chemotherapy and radiotherapy. The authors mentioned their own experiences too. Current means of preservation of reproductive status of young patients undergoing cytostatic treatment are summarized. Particularly means of pharmacological preservation of ovarial functions by administrating gonadotropin-releasing hormone analogues as well as methods of assisted reproduction.
Key words:
Hodgkin lymphoma, gonadal toxicity, early ovarial failure, gonadotropin-releasing hormone analogues, sperm kryoconzervation, assisted reproduction
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
2005 Issue 4
Most read in this issue
- Could lupus anticoagulants presence influence anticoagulant treatment in patients with antiphospholipid syndrome?
- A combined antigen-antibody HCV detection assay
- History and present of the treatment of lymphoblastic leukemia in children
- ProC®global in patients with antiphospolipid antibodies